Long‐term real‐world outcomes of patients with acute promyelocytic leukaemia treated with arsenic trioxide and all‐trans retinoic acid without chemotherapy—a retrospective, single‐centre study
Charanpreet Singh(Post Graduate Institute of Medical Education and Research), Pankaj Malhotra(Post Graduate Institute of Medical Education and Research), Alka Khadwal(Post Graduate Institute of Medical Education and Research), Deepesh Lad(Post Graduate Institute of Medical Education and Research), Nishant Jindal(Post Graduate Institute of Medical Education and Research), Saloni Rani Kumar(Government Medical College and Hospital), Uday Yanamandra(Army Hospital Research and Referral), Aditya Jandial(Post Graduate Institute of Medical Education and Research), Reena Das(Post Graduate Institute of Medical Education and Research), Shano Naseem(Post Graduate Institute of Medical Education and Research), Chandan Krushna Das(Post Graduate Institute of Medical Education and Research), Parathan Karunakaran(Cancer Institute (WIA)), Neha Saini(Post Graduate Institute of Medical Education and Research), Arihant Jain(California University of Pennsylvania), Neelam Varma(Nagpur Institute of Technology), Subhash Varma(Post Graduate Institute of Medical Education and Research), Gaurav Prakash(Post Graduate Institute of Medical Education and Research)
Cited by 15
Related Papers
Global Burden of Multiple Myeloma
|JAMA Oncology|2018|631
X-Linked Dyskeratosis Congenita Is Predominantly Caused by Missense Mutations in the DKC1 Gene
|The American Journal of Human Genetics|1999|264
Visceral leishmaniasis associated hemophagocytic lymphohistiocytosis – Case report and systematic review
|Journal of Infection|2008|114
Imatinib has adverse effect on growth in children with chronic myeloid leukemia
|Pediatric Blood & Cancer|2011|95
Growth failure in children with chronic myeloid leukemia receiving imatinib is due to disruption of GH/IGF‐1 axis
|Pediatric Blood & Cancer|2013|85